KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Oscar Health (OSCR) Income from Non-Controlling Interests (2021 - 2025)

Oscar Health's Income from Non-Controlling Interests history spans 5 years, with the latest figure at $177000.0 for Q4 2025.

  • For Q4 2025, Income from Non-Controlling Interests fell 32.44% year-over-year to $177000.0; the TTM value through Dec 2025 reached $248000.0, down 64.01%, while the annual FY2025 figure was $248000.0, 64.01% down from the prior year.
  • Income from Non-Controlling Interests reached $177000.0 in Q4 2025 per OSCR's latest filing, up from -$34000.0 in the prior quarter.
  • In the past five years, Income from Non-Controlling Interests ranged from a high of $1.2 million in Q4 2021 to a low of -$2.2 million in Q1 2022.
  • Average Income from Non-Controlling Interests over 5 years is -$60352.9, with a median of $105000.0 recorded in 2024.
  • Peak YoY movement for Income from Non-Controlling Interests: skyrocketed 168.2% in 2024, then crashed 223.81% in 2025.
  • A 5-year view of Income from Non-Controlling Interests shows it stood at $1.2 million in 2021, then tumbled by 143.56% to -$514000.0 in 2022, then skyrocketed by 137.35% to $192000.0 in 2023, then skyrocketed by 36.46% to $262000.0 in 2024, then crashed by 32.44% to $177000.0 in 2025.
  • Per Business Quant, the three most recent readings for OSCR's Income from Non-Controlling Interests are $177000.0 (Q4 2025), -$34000.0 (Q3 2025), and -$130000.0 (Q2 2025).